SCP Investment Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$2.15M |
| 2 |
ConocoPhillips
COP
|
+$1.58M |
| 3 |
Sempra
SRE
|
+$1.43M |
| 4 |
Vistra
VST
|
+$1.42M |
| 5 |
Halliburton
HAL
|
+$1.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$11.2M |
| 2 |
Caesars Entertainment
CZR
|
+$10.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$5.5M |
| 4 |
GOOS
Canada Goose Holdings
GOOS
|
+$4.53M |
| 5 |
LINE
Lineage Inc
LINE
|
+$3.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 30.39% |
| 2 | Technology | 19.73% |
| 3 | Communication Services | 13.54% |
| 4 | Consumer Discretionary | 13.34% |
| 5 | Utilities | 11.8% |
No holdings matched the selected filter criteria.
Similar funds
SCP Investment's Q1 2026 Portfolio in Review
As of Q1 2026, SCP Investment held 58 positions worth $90.3M, down 26% from $122M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
SCP Investment withdrew a net $34.9M in Q1 2026, closing 10 positions and reducing 15 holdings. Its most notable exit was DraftKings, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 24% a quarter earlier, followed by Technology and Communication Services.
Against the trend, SCP Investment opened a new position in Array Technologies worth $1.68M.
- SCP Investment's largest Q1 2026 buy was Array Technologies: 232,800 shares worth $1.68M.
- SCP Investment added most to ConocoPhillips in Q1 2026, an estimated $1.58M increase.
- SCP Investment's biggest Q1 2026 reduction was Caesars Entertainment, cutting an estimated $10.1M.
- SCP Investment fully exited DraftKings in Q1 2026, selling an estimated $11.2M.
- SCP Investment's ten largest holdings make up 59% of its $90.3M portfolio in Q1 2026.
- SCP Investment opened 17 new positions and closed 10 in Q1 2026.
- SCP Investment's portfolio value fell 26% quarter-over-quarter to $90.3M.
Based on SCP Investment's 13F filing for Q1 2026, filed 12 May 2026.